A report on embryonic stem (ES) cells differentiation, with potential implications for future regenerative therapies published by a team of researchers primarily from the Broad Institute of Harvard and MIT.
Every cell in the human body contains the same genes, but the cells in a particular type of tissue will only have the master regulatory genes associated with that tissue type activated and will have other master regulatory genes deactivated. ES cells have the potential to become any other type of tissue cell, but how they do so is not clear and is essential if treatments are to be developed from research.
This process of activating master regulatory genes is facilitated by chromatin, a histone protein structure that contains a cell’s DNA. If there is a methyl group anchored in a certain place on one histone protein, the gene nearby is activated (known as the K4 state). Conversely, if the methyl group attaches itself to another part of the protein, the gene is deactivated (known as the K27 state).
“What we found was that [mouse ES cells] have a chromatin signature that other cells don’t have—they have both a K4 and K27 signature, which was surprising because we thought they were mutually exclusive,” said Bradley E. Bernstein, assistant professor of pathology at Massachusetts General Hospital and Harvard Medical School, and the lead author of the study.
“For genes, this is equivalent to resting one finger on the trigger,” said Stuart L. Schreiber, Loeb professor and chair of the department of chemistry and chemical biology and an author of the study, in a statement.
“This approach could be a key strategy for keeping crucial genes quiet, but primed for when they will be most needed.”
While the discovery does not in and of itself explain how an ES cell differentiates itself, it provides hints for the mechanisms that might guide this process.
Moreover, the discovery of these “bivalent chromatin structures” may have important implications for branches other than stem cell medicine as well.
“I think that understanding how these sorts of bivalent structures contribute to the unique potential of these kind of cells has important implications not only for stem cell biology and regenerative medicine, but for cancer and other diseases where chromatin misregulation or deregulation is involved,” Bernstein said.
Link
Filed under Stem Cell | Comment Below
Minerva study likely to provide breakthrough to stem cell growth and differentiation October 4th, 2008 This can be called as the major step towards understanding of the stem cell growth and differentiation mechanisms. The Minerva Biotechnologies,in collaboration with the University of California discovered that a single, new growth factor can not only support massive growth of human embryonic stem cells (hESCs) in vitro, but also maintains them in a nearly 100% undifferentiated state without the need for fibroblast "feeder cells".
Breakthrough in Safer Stem Cell Transplantation from Hong KongDecember 7th, 2005 Ion channels discovered in human embryonic stem cells will make the cells safer for clinical use announced University of Hong Kong. Embryonic stem cell is the only type of human stem cells capable of becoming all human cell types, including highly specialized cells such as brain and heart cells.
Key mechanism in neural stem cells differentiation: breakthrough in cancer studyNovember 12th, 2008 A University of Southern California stem cell study can be a breakthrough in the regenerative medicine and cancer therapies. The researchers have found protein receptor Ryk has a key role in the differentiation of neural stem cells.
New research proves the involvement of small molecules in determining the shape of stem cellsSeptember 26th, 2008 Latest stem cell research shows that the fate of cells, like when a stem cell becomes a muscle cell or brain cell, depends on a special kind of small molecules known as morphogens. This innovative research was started to understand how tissue form can lead to the differentiation of cells in the appropriate locations.
Newly Identified Gene Family UTX-JMJD3 Essential for Embryonic Stem Cell DevelopmentAugust 25th, 2007 UTX-JMJD3, a new gene family which controls the expression of genes crucial for stem cell maintenance and differentiation has been identified by the researchers at BRIC, University of Copenhagen. These results have been obtained by using both human and mouse stem cells, as well as by studying the devel-opment of the round worm, C.
Stem cell therapy may help treat deafnessMarch 24th, 2009 WASHINGTON - In a breakthrough study, researchers have developed a new stem cell therapy that may help in treating hearing impairment. Deafness typically involves the loss of sensory receptors, called hair cells, for their "tufts" of hair-like protrusions, and their associated neurons.
Revolutionary Stem Cell Study Finds Key to Large Scale Stem Cell Production for Therapeutic Use May 22nd, 2008 The researchers at the University of Southern California have found that the the embryonic stem cell will remain undifferentiated if they are shielded from differentiation signals. By applying the small molecules that block the chemicals from activating the differentiation process, the natural default of the cell is to self-renew, or multiply, as generic stem cells.
Embryonic Stem Cell Differentiation initializes by a key protein Shp2March 20th, 2009 This new research which was published online in the journal PLoS One on March 17, 2009, differs with some earlier findings that suggested hESCs and mESCs differentiate as a result of different signaling mechanisms. Researchers at Burnham Institute for Medical Research (Burnham) have found that a protein called Shp2 plays a critical role in the pathways that control decisions for differentiation or self-renewal in both human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs).
